Breaking News Instant updates and real-time market news.

PG

Procter & Gamble

$84.56

-0.47 (-0.55%)

, KO

Coca-Cola

$41.48

-0.2625 (-0.63%)

10:08
01/09/17
01/09
10:08
01/09/17
10:08

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Sell at Goldman with analyst Jason English lowering the Home and Personal Care, or HPC, sector to Cautious from Neutral saying potentially rising rates are a headwind to valuation, expects fundamentals to remain challenged on sluggish end market demand and big brand share challenges, and incremental headwinds from the rising US dollar. Against this backdrop, English downgraded Procter & Gamble to Sell and lowered its price target to $77 from $86 due to a "stretched" valuation and estimate risk if the turnaround falters. 2. Coca-Cola (KO) downgraded to Sell from Neutral at Goldman with analyst Jason English saying he sees less potential benefit from tax policy for large multi-nationals and estimate risk from sub-par organic sales growth. The analyst lowered his price target to $39 from $41. 3. Philip Morris (PM) downgraded to Buy from Conviction Buy at Goldman with analyst Judy Hong citing increased foreign exchange risk. 4. Weatherford (WFT) downgraded to Equal Weight from Overweight at Barclays with analyst J. David Anderson citing uncertainty around management and the company's strategy. The analyst also raised his view on the Oilfield Services space to Positive from Neutral. He lowered his price target for Weatherford shares to $7 from $8. 5. VMware (VMW) downgraded to Neutral from Buy at UBS with analyst Brent Thill citing his "increasingly selective" stance for U.S. Software stocks in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

PG

Procter & Gamble

$84.56

-0.47 (-0.55%)

KO

Coca-Cola

$41.48

-0.2625 (-0.63%)

PM

Philip Morris

$91.15

-0.69 (-0.75%)

WFT

Weatherford

$5.76

-0.15 (-2.54%)

VMW

VMware

$80.19

-1.315 (-1.61%)

  • 02

    Feb

  • 20

    Feb

  • 09

    May

PG Procter & Gamble
$84.56

-0.47 (-0.55%)

12/22/16
RHCO
12/22/16
DOWNGRADE
RHCO
Hold
Procter & Gamble downgraded on negative catalysts at SunTrust
As noted earlier, SunTrust downgraded Procter & Gamble to Hold from Buy. Analyst William Chappell, Jr. predicts that, "foreign exchange headwinds and waning investor appetites for higher yields" will cause the stock "to stay in a trading range in coming quarters." Target to $85 from $95.
12/22/16
RHCO
12/22/16
DOWNGRADE
RHCO
Hold
Procter & Gamble downgraded to Hold from Buy at SunTrust
01/09/17
GSCO
01/09/17
DOWNGRADE
GSCO
Sell
Procter & Gamble downgraded to Sell, HPC sector to Cautious at Goldman
Goldman analyst Jason English lowered Home and Personal Care, or HPC, sector to Cautious from Neutral saying potentially rising rates are a headwind to valuation, expects fundamentals to remain challenged on sluggish end market demand and big brand share challenges, and incremental headwinds from the rising US dollar. Against this backdrop, English downgraded Procter & Gamble to Sell and lowered its price target to $77 from $86 due to a "stretched" valuation and estimate risk if the turnaround falters. The analyst lowered estimates saying he sees incremental risk to organic growth as last quarter's organic sales of 3.5% may prove unsustainable and comparisons become more difficult. English said the promotional surge could fail to translate into share gains and expects sustained market share vulnerability if Procter purses its maga-brand strategy in a growing fragmented market.
12/22/16
12/22/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at SunTrust with analyst William Chappell, Jr. predicting that, "foreign exchange headwinds and waning investor appetites for higher yields" will cause the stock "to stay in a trading range in coming quarters." 2. Praxair (PX) downgraded to Underperform from Outperform at CLSA. 3. Bed Bath & Beyond (BBBY) downgraded to Market Perform from Strong Buy at Raymond James with analyst Budd Bugatch saying Bed Bath still has a long runway ahead before it realizes benefits from technology investments, membership program, and recent investments in One Kings Lane and PMall.com. 4. Finish Line (FINL) downgraded to Neutral from Buy at Monness Crespi, to Neutral from Outperform at Wedbush, to Hold from Buy at Canaccord, to Neutral from Buy at B. Riley, and to Neutral from Buy at BofA/Merrill. 5. Red Hat (RHT) downgraded to Hold from Buy at Stifel and to Market Perform from Outperform at BMO Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
KO Coca-Cola
$41.48

-0.2625 (-0.63%)

12/21/16
JEFF
12/21/16
UPGRADE
Target $58
JEFF
Buy
Monster Beverage upgraded to Buy from Hold at Jefferies
Jefferies analyst Kevin Grundy upgraded Monster Beverage (MNST) to Buy and calls the stock his top large cap growth pick in Consumer Products. The analyst highlights Monster's accelerating sales growth in the U.S. and international market share gains. He views the current valuation as attractive and sees strategic optionality should Coca-Cola (KO) acquire the remaining 82% of the shares it does not own. Grundy raised his price target for Monster Beverage shares to $58 from $53.
01/09/17
LEHM
01/09/17
INITIATION
Target $42
LEHM
Equal Weight
Coca-Cola initiated with an Equal Weight at Barclays
Barclays analyst Lauren Lieberman started Coca-Cola with an Equal Weight rating and $42 price target.
12/16/16
12/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Coca-Cola (KO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Dara Mohsenian seeing Coke's top-line growth prospects as muted, slightly below its mega-cap peers and expects mega-cap multinationals to underperform due to U.S. dollar strength and sector rotation. 2. Apache (APA) downgraded to Market Perform from Outperform at Wells Fargo with analyst David Tameron citing headwinds from service cost increases, slowing efficiency gains and uncertain long-term price expectations. 3. Nordstrom (JWN) downgraded to Underweight from Neutral at JPMorgan analyst Matthew Boss saying he sees "silver bullets" for the company to accelerate sales growth after meeting with management. 4. Noble Corp. (NE) downgraded to Underperform from Sector Perform at RBC Capital and to Sell from Neutral at Goldman. 5. Weight Watchers (WTW) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying Weight Watchers Google search trends have been weaker in major markets and views 2018 guidance as too optimistic as Oprah Winfrey partnership benefits fade in 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/17
GSCO
01/09/17
DOWNGRADE
GSCO
Sell
Coca-Cola downgraded to Sell from Neutral at Goldman
Goldman analyst Jason English lowered Home and Personal Care, or HPC, sector to Cautious from Neutral saying potentially rising rates are a headwind to valuation, expects fundamentals to remain challenged on sluggish end market demand and big brand share challenges, and incremental headwinds from the rising US dollar. Against this backdrop, English downgraded Coca-Cola to Sell and lowered its price target to $39 from $41 saying its sees less potential benefit from tax policy for large multi-nationals and estimate risk from sub-par organic sales growth.
PM Philip Morris
$91.15

-0.69 (-0.75%)

01/04/17
01/04/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan analyst Richard Vosser downgraded Novartis (NVS) to Neutral from Overweight saying pressures on the company's business are mounting. The pressure from generic erosion in 2017 "remains high" with an estimated $2.3B of sales expected to be lost to generics, said Vosser, who sees "significant downside" to consensus estimates for Novartis. 2. BofA Merrill Lynch analyst Lisa Lewandowski downgraded Philip Morris (PM) to Neutral from Buy and lowered its price target to $96 from $102 citing concerns from the strong U.S. dollar, less impact from an overhaul in U.S. tax policy versus peers, underperformance in combustible tobacco volumes, increasing heat-not-burn competition, a rotation out of defensive/bond proxy assets, and debt convent constraints. 3. Jefferies analyst Andy Barish downgraded Dunkin' Brands (DNKN) to Underperform from Hold, saying he does not believe the company's same-store-sales have broken out above 2% while its international growth has been disappointing. Barish also downgraded Cheesecake Factory (CAKE) to Underperform, citing the 15% post-election rally with no change in fundamentals along with the company's "significant" mall exposure. 4. Evercore ISI downgraded Intuitive Surgical (ISRG) to Hold from Buy and lowered its price target to $690 from $780, with analyst Vijay Kumar saying he expects 2017 to be one of the most challenging for healthcare in general, with the sector facing issues ranging from ACA repeal to border tax reform to interest expense deductibility. 5. Cowen analyst Helane Becker downgraded a number of airline stocks, including United Continental (UAL), JetBlue (JBLU), Alaska Air (ALK) and American Airlines (AAL), to Market Perform from Outperform based on valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/17
BOFA
01/04/17
DOWNGRADE
Target $96
BOFA
Neutral
Philip Morris downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Lisa Lewandowski downgraded Philip Morris to Neutral and lowered its price target to $96 from $102 citing concerns from the strong US dollar, less impact from an overhaul in US tax policy versus peers, underperformance in combustible tobacco volumes, increasing heat-not-burn competition, a rotation out of defensive/bond proxy assets, and debt convent constraints.
01/09/17
01/09/17
DOWNGRADE
Target $109

Buy
Philip Morris downgraded to Buy from Conviction Buy at Goldman
As previously reported, Goldman analyst Judy Hong removed Philip Morris from the firm's Conviction Buy List due to increased foreign exchange risk. The analyst maintained her Buy rating and $109 price target saying Philip Morris' iQos platform is a leading example of innovation within Staples as the company looks to disrupt the global cigarette industry.
12/19/16
WELS
12/19/16
NO CHANGE
WELS
Likelihood of Altria Group acquisition has increased, says Wells Fargo
Wells Fargo says that the chances of Philip Morris (PM) acquiring Altria Group (MO) in the next 6-12 months have increased to 70%. The firm cites several reasons for its view, including what it sees as the increased attractiveness of the U.S. market, global consolidation in the sector, and its belief that the value of Philip Morris' smokeless cigarettes will increase if it acquires Altria. The firm keeps Outperform ratings on both stocks and names Altria its new top stock pick.
WFT Weatherford
$5.76

-0.15 (-2.54%)

11/10/16
LYON
11/10/16
UPGRADE
LYON
Buy
Weatherford upgraded to Buy from Underperform at CLSA
CLSA analyst David Havens upgraded Weatherford to Buy from Underperform and raised its price target to $8 from $5 following news that Bernard Duroc-Danner is no longer CEO. The analyst believes this is a step towards restoring investor confidence and that Weatherford could be a turnaround stock.
12/01/16
BERN
12/01/16
INITIATION
Target $7
BERN
Outperform
Weatherford initiated with an Outperform at Bernstein
Bernstein analyst Colin Davies initiated Weatherford with an Outperform and a $7 price target.
12/02/16
BERN
12/02/16
INITIATION
BERN
Outperform
Weatherford initiated at Bernstein
As noted earlier, Bernstein analyst Colin Davies initiated Weatherford with an Outperform rating and a $7 price target. The analyst thinks that the company is poised to benefit from the revival of the North America oil market, and he expects its revenue growth to beat expectations. He is less upbeat about the outlook for the company's margins, and his EBITDA outlook for the company is in-line with the consensus estimate. However, Davies believes that free cash flow increases and liquidity improvements can drive the stock higher in the near-term.
01/09/17
LEHM
01/09/17
DOWNGRADE
Target $7
LEHM
Equal Weight
Weatherford downgraded to Equal Weight from Overweight at Barclays
Barclays analyst J. David Anderson downgraded Weatherford to Equal Weight citing uncertainty around management and the company's strategy. The analyst also raised his view on the Oilfield Services space to Positive from Neutral. He lowered his price target for Weatherford shares to $7 from $8.
VMW VMware
$80.19

-1.315 (-1.61%)

01/06/17
CLVD
01/06/17
NO CHANGE
CLVD
VMware Q4 modeled at high end of guidance at Cleveland Research
Cleveland Research analyst Ben Bollin said checks indicate encouraging 4Q demand with results viewed at the high end of guidance. The analyst said discussions into 2017 remain encouraging with favorable backlog, additional large deal momentum, and potential for greater contribution from the AWS and Dell relationship.
01/09/17
UBSW
01/09/17
DOWNGRADE
UBSW
Neutral
VMware downgraded to Neutral from Buy at UBS
UBS analyst Brent Thill downgraded VMware to Neutral citing his "increasingly selective" stance for U.S. Software stocks in 2017.
12/06/16
OPCO
12/06/16
NO CHANGE
OPCO
VMware, Microsoft viewed as strategic in enabling hybrid cloud, says Oppenheimer
Following Amazon (AMZN) Web Services re:Invent conference, Oppenheimer analyst Ittai Kidron says the company's development efforts appear to be around delivering more complete solutions, turning AWS into a platform for data management, analytics, and artificial intelligence. According to interviews conducted at the conference, the analyst says the shift to the cloud is going to accelerate in coming years, but implementation of public cloud is still complex. Additionally, the results suggest that VMware (VMW) and Microsoft (MSFT) are viewed as "most strategic" to implementing hybrid clouds. Further, Kidron says the survey is negative for most traditional on premise vendors, and believes the vendors most likely to see headwinds include Dell/EMC (EMC), NetApp (NTAP), HP Enterprise (HPE), IBM (IBM), and Cisco (CSCO).
12/01/16
OPCO
12/01/16
NO CHANGE
OPCO
Outperform
Amazon continues to attack large, emerging opportunities, says Oppenheimer
Commenting on the first day of Amazon's (AMZN) Amazon Web Services re:Invent conference, Oppenheimer analyst Jason Helfstein notes that AWS targeted Oracle's (ORCL) database services and highlighted more artificial intelligence functionality in line with Google's (GOOG; GOOGL)/Microsoft (MSFT). The analyst says Amazon also touched on its partnership with VMware (VMW), which should help enterprise migration. Helfstein believes AWS continues to attack large/emerging opportunities while continuing to simplify/automate the development process. He reiterates an Outperform rating on Amazon's shares.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$910.67

-0.31 (-0.03%)

, GOOGL

Alphabet Class A

$926.18

-1.48 (-0.16%)

16:32
08/19/17
08/19
16:32
08/19/17
16:32
Periodicals
Google working on new tools to boost news subscriptions, WSJ reports »

Google is said to be…

GOOG

Alphabet

$910.67

-0.31 (-0.03%)

GOOGL

Alphabet Class A

$926.18

-1.48 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

SRE

Sempra Energy

$116.55

0.76 (0.66%)

, BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

16:27
08/19/17
08/19
16:27
08/19/17
16:27
Periodicals
Sempra Energy is third bidder for Oncor Electric, Bloomberg reports »

Sempra Energy (SRE) is…

SRE

Sempra Energy

$116.55

0.76 (0.66%)

BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

16:20
08/19/17
08/19
16:20
08/19/17
16:20
Periodicals
Advance Auto Parts hit wall on Q2 results, but turnaround intact, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$34.38

-13.32 (-27.92%)

, AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

16:13
08/19/17
08/19
16:13
08/19/17
16:13
Periodicals
Retail stocks swings could provide opportunity, Barron's says »

This earnings season,…

FL

Foot Locker

$34.38

-13.32 (-27.92%)

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

LB

L Brands

$36.20

-1.35 (-3.60%)

URBN

Urban Outfitters

$19.27

0.33 (1.74%)

ROST

Ross Stores

$59.02

5.69 (10.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$32.67

-0.28 (-0.85%)

, BMY

Bristol-Myers

$56.42

-0.35 (-0.62%)

16:05
08/19/17
08/19
16:05
08/19/17
16:05
Periodicals
Pharmaceutical companies not the only ones with healthy dividends, Barron's says »

Most income investors are…

PFE

Pfizer

$32.67

-0.28 (-0.85%)

BMY

Bristol-Myers

$56.42

-0.35 (-0.62%)

CAH

Cardinal Health

$64.38

-0.78 (-1.20%)

PDCO

Patterson Companies

$36.45

-0.31 (-0.84%)

RMD

ResMed

$73.07

0.28 (0.38%)

ABC

AmerisourceBergen

$78.60

-1.34 (-1.68%)

UNH

UnitedHealth

$190.82

-1.88 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 27

    Aug

  • 28

    Aug

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

  • 11

    Sep

  • 11

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 09

    Nov

  • 05

    Mar

GDI

Gardner Denver

$21.97

-0.03 (-0.14%)

, KKR

KKR

$18.14

0.11 (0.61%)

15:54
08/19/17
08/19
15:54
08/19/17
15:54
Periodicals
Gardner Denver integrated strategy beginning to pay off, Barron's says »

Under KKR (KKR), who…

GDI

Gardner Denver

$21.97

-0.03 (-0.14%)

KKR

KKR

$18.14

0.11 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSI

Motorola Solutions

$87.37

0.24 (0.28%)

, T

AT&T

$37.37

-0.23 (-0.61%)

15:47
08/19/17
08/19
15:47
08/19/17
15:47
Periodicals
Public-safety broadband network may supplant Motorola systems, Barron's says »

FirstNet has tapped…

MSI

Motorola Solutions

$87.37

0.24 (0.28%)

T

AT&T

$37.37

-0.23 (-0.61%)

CCI

Crown Castle

$104.12

-0.02 (-0.02%)

SBAC

SBA Communications

$142.90

0.69 (0.49%)

AMT

American Tower

$140.00

0.35 (0.25%)

COMM

CommScope

$33.00

0.16 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

15:39
08/19/17
08/19
15:39
08/19/17
15:39
Periodicals
Lockheed Martin should benefit from boost in military outlays, Barron's says »

Large-cap defense stocks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

15:26
08/19/17
08/19
15:26
08/19/17
15:26
Periodicals
Starbucks could jump 20%, Barron's says »

There were plenty of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 02

    Nov

  • 25

    Jan

MRK

Merck

$61.49

-0.35 (-0.57%)

, INTC

Intel

$35.01

-0.16 (-0.45%)

15:05
08/19/17
08/19
15:05
08/19/17
15:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

MRK

Merck

$61.49

-0.35 (-0.57%)

INTC

Intel

$35.01

-0.16 (-0.45%)

UA

Under Armour

$15.64

-0.64 (-3.93%)

UAA

Under Armour

$17.12

-0.69 (-3.87%)

CPB

Campbell Soup

$53.69

-0.27 (-0.50%)

JNJ

Johnson & Johnson

$132.63

-0.41 (-0.31%)

UTX

United Technologies

$115.48

-0.62 (-0.53%)

BX

Blackstone

$31.52

-0.08 (-0.25%)

JPM

JPMorgan

$90.74

0.09 (0.10%)

GM

General Motors

$34.83

-0.17 (-0.49%)

WMT

Wal-Mart

$79.31

-0.39 (-0.49%)

TSLA

Tesla

$347.46

-4.46 (-1.27%)

DIS

Disney

$100.70

-0.68 (-0.67%)

AMZN

Amazon.com

$958.47

-2.1 (-0.22%)

AET

Aetna

$154.45

-1.36 (-0.87%)

ANTM

Anthem

$191.02

-0.94 (-0.49%)

CNC

Centene

$83.49

-0.13 (-0.16%)

CI

Cigna

$177.03

-1 (-0.56%)

HNT

Health Net

HUM

Humana

$247.28

-0.38 (-0.15%)

MOH

Molina Healthcare

$59.63

0.12 (0.20%)

UNH

UnitedHealth

$190.82

-1.88 (-0.98%)

WCG

WellCare

$173.56

-2.2 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 31

    Aug

  • 05

    Sep

  • 06

    Sep

  • 07

    Sep

  • 08

    Sep

  • 11

    Sep

  • 12

    Sep

  • 22

    Sep

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 12

    Oct

  • 08

    Nov

  • 16

    Nov

  • 20

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

CTL

CenturyLink

$19.16

-0.22 (-1.14%)

, LVLT

Level 3

$52.69

-0.3 (-0.57%)

14:52
08/19/17
08/19
14:52
08/19/17
14:52
Hot Stocks
CenturyLink continues to expect acquisition of Level 3 to be complete by Q3 »

CenturyLink (CTL) said in…

CTL

CenturyLink

$19.16

-0.22 (-1.14%)

LVLT

Level 3

$52.69

-0.3 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.